Allianz Asset Management
TEVA icon

Allianz Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Allianz Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Buy
568,512
+6,508
+1% +$209K 0.02% 667
2025
Q4 		$17.5M Sell
562,004
-12,418
-2% -$306K 0.02% 652
2025
Q3 		$11.6M Sell
574,422
-69,654
-11% -$1.22M 0.01% 786
2025
Q2 		$10.8M Sell
644,076
-34,916
-5% -$563K 0.01% 784
2025
Q1 		$10.4M Buy
678,992
+73,601
+12% +$1.31M 0.01% 794
2024
Q4 		$13.3M Sell
605,391
-86,099
-12% -$1.57M 0.02% 661
2024
Q3 		$12.5M Buy
691,490
+81,295
+13% +$1.42M 0.02% 670
2024
Q2 		$9.92M Sell
610,195
-742,370
-55% -$11.4M 0.01% 692
2024
Q1 		$19.1M Sell
1,352,565
-750,249
-36% -$9.46M 0.03% 487
2023
Q4 		$22M Sell
2,102,814
-794,934
-27% -$7.42M 0.04% 435
2023
Q3 		$29.6M Sell
2,897,748
-151,721
-5% -$1.41M 0.05% 369
2023
Q2 		$23M Sell
3,049,469
-137,385
-4% -$1.11M 0.04% 418
2023
Q1 		$28.2M Buy
3,186,854
+595,548
+23% +$5.89M 0.05% 379
2022
Q4 		$23.6M Buy
2,591,306
+478,741
+23% +$4.18M 0.05% 418
2022
Q3 		$17M Buy
2,112,565
+373,402
+21% +$3.3M 0.03% 512
2022
Q2 		$13.1M Buy
1,739,163
+51,811
+3% +$451K 0.01% 816
2022
Q1 		$15.8M Buy
+1,687,352
New +$14.1M 0.01% 828
2021
Q2 		– Sell
-613,127
Closed -$7.08M – 2479
2021
Q1 		$7.08M Sell
613,127
-1,506,839
-71% -$17.3M 0.01% 942
2020
Q4 		$20.5M Buy
2,119,966
+7,730
+0.4% +$74.1K 0.02% 609
2020
Q3 		$19M Sell
2,112,236
-419,138
-17% -$4.43M 0.02% 585
2020
Q2 		$31.2M Buy
2,531,374
+305,830
+14% +$3.46M 0.04% 467
2020
Q1 		$20M Buy
2,225,544
+245,022
+12% +$2.51M 0.03% 558
2019
Q4 		$19.4M Sell
1,980,522
-22,937
-1% -$205K 0.02% 795
2019
Q3 		$13.8M Sell
2,003,459
-47,381
-2% -$363K 0.01% 943
2019
Q2 		$18.9M Buy
2,050,840
+18,429
+0.9% +$222K 0.02% 835
2019
Q1 		$31.9M Sell
2,032,411
-134,167
-6% -$2.37M 0.03% 564
2018
Q4 		$33.4M Buy
+2,166,578
New +$44.4M 0.04% 497
2018
Q2 		– Sell
-171,697
Closed -$2.93M – 2711
2018
Q1 		$2.93M Sell
171,697
-20,000
-10% -$390K ﹤0.01% 1756
2017
Q4 		$3.63M Sell
191,697
-326,867
-63% -$4.92M ﹤0.01% 1770
2017
Q3 		$9.13M Buy
518,564
+45,998
+10% +$1.03M 0.01% 1359
2017
Q2 		$15.6M Sell
472,566
-680,996
-59% -$21.1M 0.02% 1091
2017
Q1 		$37M Sell
1,153,562
-469,173
-29% -$16M 0.04% 650
2016
Q4 		$58.8M Buy
1,622,735
+5,659
+0.3% +$226K 0.05% 460
2016
Q3 		$74.5M Sell
1,617,076
-54,912
-3% -$2.86M 0.07% 295
2016
Q2 		$84M Sell
1,671,988
-5,468,640
-77% -$291M 0.09% 254
2016
Q1 		$382M Sell
7,140,628
-440,902
-6% -$25.9M 0.43% 40
2015
Q4 		$498M Sell
7,581,530
-909,566
-11% -$56.2M 0.56% 30
2015
Q3 		$479M Sell
8,491,096
-1,346,841
-14% -$87.3M 0.57% 32
2015
Q2 		$581M Sell
9,837,937
-1,571,013
-14% -$96.9M 0.62% 24
2015
Q1 		$711M Sell
11,408,950
-448,230
-4% -$26.1M 0.81% 17
2014
Q4 		$682M Buy
11,857,180
+16,214
+0.1% +$903K 0.76% 18
2014
Q3 		$634M Sell
11,840,966
-989,135
-8% -$52.4M 0.76% 20
2014
Q2 		$673M Sell
12,830,101
-768,692
-6% -$39.3M 0.84% 14
2014
Q1 		$719M Sell
13,598,793
-2,522,791
-16% -$117M 0.86% 13
2013
Q4 		$646M Sell
16,121,584
-556,935
-3% -$21.9M 0.82% 15
2013
Q3 		$630M Buy
16,678,519
+2,041,547
+14% +$79.6M 0.83% 18
2013
Q2 		$574M Buy
+14,636,972
New +$570M 0.81% 17

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's TEVA Position: Q1 2026 in Review

Allianz Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 1.2% in Q1 2026, buying an estimated $209K and bringing the position to 568,512 shares worth $17.1M. The position accounts for 0.02% of the portfolio, ranked #667.

Allianz Asset Management first reported a position in TEVA in Q2 2013 and has held it in 47 quarters since. The position peaked at $719M in Q1 2014. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Allianz Asset Management held 568,512 shares of Teva Pharmaceuticals worth $17.1M as of Q1 2026.
  • Allianz Asset Management bought 6,508 Teva Pharmaceuticals shares in Q1 2026, an estimated $209K.
  • Teva Pharmaceuticals made up 0.02% of Allianz Asset Management's portfolio in Q1 2026, its #667 holding.
  • Allianz Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
  • Allianz Asset Management's Teva Pharmaceuticals position peaked at $719M in Q1 2014.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.